• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究参与者对早期肿瘤试验中获益的高期望:我们是否问了正确的问题?

Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

机构信息

Duke University, Durham, NC 27715, USA.

出版信息

J Clin Oncol. 2012 Dec 10;30(35):4396-400. doi: 10.1200/JCO.2011.40.6587. Epub 2012 Oct 22.

DOI:10.1200/JCO.2011.40.6587
PMID:23091107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3615308/
Abstract

PURPOSE

To determine whether patients' expectations of benefit in early-phase oncology trials depend on how patients are queried and to explore whether expectations are associated with patient characteristics.

PATIENTS AND METHODS

Participants were 171 patients in phase I or II oncology trials in the United States. After providing informed consent for a trial but before receiving the investigational therapy, participants answered questions about expectations of benefit. We randomly assigned participants to one of three groups corresponding to three queries about expectations: frequency type, belief type, or both. Main outcomes were differences in expectations by question type and the extent to which expectations were associated with demographic characteristics, numeracy, dispositional optimism, religiousness/spirituality, understanding of research, and other measures.

RESULTS

The belief-type group had a higher mean expectation of benefit (64.4 of 100) than the combination group (51.6; P = .01) and the frequency-type group (43.1; P < .001). Mean expectations in the combination and frequency groups were not significantly different (P = .06). Belief-type expectations were associated with a preference for nonquantitative information (r = -0.19; 95% CI, -0.19 to -0.36), knowledge about research (r = -0.21; 95% CI, -0.38 to -0.03), dispositional optimism (r = 0.20; 95% CI, 0.01 to 0.37), and spirituality (r = 0.22; 95% CI, 0.03 to 0.38). Frequency-type expectations were associated with knowledge about clinical research (r = -0.27; 95% CI, -0.27 to -0.51).

CONCLUSION

In early-phase oncology trials, patients' reported expectations of benefit differed according to how patients were queried and were associated with patient characteristics. These findings have implications for how informed consent is obtained and assessed.

摘要

目的

确定患者对早期肿瘤试验获益的期望是否取决于患者的提问方式,并探讨这些期望是否与患者特征相关。

方法

本研究在美国进行的 I 期或 II 期肿瘤试验中纳入了 171 名患者。在签署知情同意书参与试验但尚未接受试验性治疗之前,参与者回答了关于获益期望的问题。我们将参与者随机分配到三个问题组之一,对应三种询问期望的方式:频率类型、信念类型或两者兼而有之。主要结局是不同问题类型之间的期望差异,以及期望与人口统计学特征、计算能力、倾向性乐观、宗教/精神信仰、对研究的理解以及其他措施的相关性。

结果

信念类型组的平均获益期望(64.4 分[100 分制])高于组合组(51.6;P=0.01)和频率类型组(43.1;P<0.001)。组合组和频率组的平均期望没有显著差异(P=0.06)。信念类型的期望与对非定量信息的偏好(r=-0.19;95%CI,-0.19 至-0.36)、对研究的了解(r=-0.21;95%CI,-0.38 至-0.03)、倾向性乐观(r=0.20;95%CI,0.01 至 0.37)和精神信仰(r=0.22;95%CI,0.03 至 0.38)相关。频率类型的期望与对临床研究的了解相关(r=-0.27;95%CI,-0.27 至-0.51)。

结论

在早期肿瘤试验中,患者报告的获益期望因提问方式而异,并且与患者特征相关。这些发现对如何获得和评估知情同意具有影响。

相似文献

1
Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?研究参与者对早期肿瘤试验中获益的高期望:我们是否问了正确的问题?
J Clin Oncol. 2012 Dec 10;30(35):4396-400. doi: 10.1200/JCO.2011.40.6587. Epub 2012 Oct 22.
2
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.早期临床试验中的获益期望:对评估知情同意充分性的影响
Med Decis Making. 2008 Jul-Aug;28(4):575-81. doi: 10.1177/0272989X08315242. Epub 2008 Mar 31.
3
Dispositional optimism and therapeutic expectations in early-phase oncology trials.早期肿瘤学试验中的性格乐观与治疗期望
Cancer. 2016 Apr 15;122(8):1238-46. doi: 10.1002/cncr.29908. Epub 2016 Feb 16.
4
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.患者特征与对I期临床试验获益期望之间的相关性。
Cancer. 2003 Jul 1;98(1):166-75. doi: 10.1002/cncr.11483.
5
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.信仰和希望的文化:参与早期肿瘤试验的患者对预期治疗获益的高度评价的理由。
Cancer. 2010 Aug 1;116(15):3702-11. doi: 10.1002/cncr.25201.
6
An intervention to improve cancer patients' understanding of early-phase clinical trials.一项旨在提高癌症患者对早期临床试验理解的干预措施。
IRB. 2009 May-Jun;31(3):1-10.
7
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.围绕参与癌症化疗I期和II期临床试验的患者动机。
Br J Cancer. 2005 Mar 28;92(6):1001-5. doi: 10.1038/sj.bjc.6602423.
8
Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.三项随机对照试验评估了“spin”(即新闻报道中的倾向性或选择性报道)对健康新闻故事中药物治疗研究结果的报道对患者/护理人员对治疗益处的理解的影响。
BMC Med. 2019 Jun 4;17(1):105. doi: 10.1186/s12916-019-1330-9.
9
Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.患者对I期临床试验获益的期望:诊断治疗错误观念中的语言因素
Theor Med Bioeth. 2003;24(4):329-44. doi: 10.1023/a:1026072409595.
10
Impact of quality of life on patient expectations regarding phase I clinical trials.生活质量对患者关于I期临床试验期望的影响。
J Clin Oncol. 2000 Jan;18(2):421-8. doi: 10.1200/JCO.2000.18.2.421.

引用本文的文献

1
Proportion of patients in phase 2 oncology trials receiving treatments that are ultimately approved.在2期肿瘤学试验中接受最终获批治疗的患者比例。
J Natl Cancer Inst. 2025 May 1;117(5):1056-1063. doi: 10.1093/jnci/djaf013.
2
Comparison of clinical outcomes among cancer patients treated in and out of clinical trials.比较临床试验内外治疗的癌症患者的临床结局。
BMC Cancer. 2023 Aug 23;23(1):786. doi: 10.1186/s12885-023-11305-3.
3
Interventions supporting cancer patients in making decisions regarding participation in clinical trials - a systematic review.支持癌症患者参与临床试验决策的干预措施 - 系统评价。
BMC Cancer. 2022 Oct 26;22(1):1097. doi: 10.1186/s12885-022-10066-9.
4
Individualized therapy trials: navigating patient care, research goals and ethics.个体化治疗试验:兼顾患者护理、研究目标和伦理学。
Nat Med. 2021 Oct;27(10):1679-1686. doi: 10.1038/s41591-021-01519-y. Epub 2021 Oct 12.
5
Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer.转移性三阴性乳腺癌患者对多次活检、多维分子分析及结果报告强化试验的态度
JCO Precis Oncol. 2017 Aug 16;1. doi: 10.1200/PO.17.00076. eCollection 2017.
6
Patient Perceptions in a Nonblinded Randomized Trial of Radiation Therapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception.患者对放射治疗技术的非盲随机试验的看法:一项探索治疗误解的新调查研究。
Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):867-875. doi: 10.1016/j.ijrobp.2020.05.021. Epub 2020 May 23.
7
Are cancer patients better off if they participate in clinical trials? A mixed methods study.癌症患者参与临床试验是否获益更多?一项混合方法研究。
BMC Cancer. 2020 May 8;20(1):401. doi: 10.1186/s12885-020-06916-z.
8
Navigating the Informed Consent Process When Using Innovative Surgery.在使用创新手术时如何进行知情同意流程
Otolaryngol Head Neck Surg. 2020 Feb;162(2):177-180. doi: 10.1177/0194599819897067. Epub 2019 Dec 24.
9
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).实现更好的关于姑息治疗和早期临床试验参与选择的医患对话:迈向在线价值澄清工具(OnVaCT)。
BMC Palliat Care. 2019 Nov 29;18(1):106. doi: 10.1186/s12904-019-0486-6.
10
Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors.目的的双重性:实体瘤患儿及青少年患者及其家长对基因组肿瘤分析研究目的的理解
JCO Precis Oncol. 2019;3. doi: 10.1200/po.18.00176. Epub 2019 Jan 22.

本文引用的文献

1
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.信仰和希望的文化:参与早期肿瘤试验的患者对预期治疗获益的高度评价的理由。
Cancer. 2010 Aug 1;116(15):3702-11. doi: 10.1002/cncr.25201.
2
An approach to evaluating the therapeutic misconception.一种评估治疗错误观念的方法。
IRB. 2009 Sep-Oct;31(5):7-14.
3
Varieties of uncertainty and the validity of informed consent.不确定性的种类与知情同意的有效性
Clin Trials. 2008;5(6):624-5; discussion 630. doi: 10.1177/1740774508098690.
4
Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?肿瘤学1期试验中的益处:治疗误解还是合理的治疗选择?
Clin Trials. 2008;5(6):617-23. doi: 10.1177/1740774508097576.
5
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.早期临床试验中的获益期望:对评估知情同意充分性的影响
Med Decis Making. 2008 Jul-Aug;28(4):575-81. doi: 10.1177/0272989X08315242. Epub 2008 Mar 31.
6
Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations.主观算术能力量表的验证:低算术能力对风险沟通理解和效用引出的影响。
Med Decis Making. 2007 Sep-Oct;27(5):663-71. doi: 10.1177/0272989X07303824. Epub 2007 Jul 24.
7
The problem with optimism in clinical trials.临床试验中的乐观主义问题。
IRB. 2006 Jul-Aug;28(4):13-9.
8
Communication and informed consent in phase 1 trials: a review of the literature.1期试验中的沟通与知情同意:文献综述
Support Care Cancer. 2006 Apr;14(4):303-9. doi: 10.1007/s00520-005-0916-2. Epub 2006 Jan 28.
9
Therapeutic misconception in early phase gene transfer trials.早期基因转移试验中的治疗性误解。
Soc Sci Med. 2006 Jan;62(1):239-53. doi: 10.1016/j.socscimed.2005.05.022. Epub 2005 Jul 5.
10
Consent forms and the therapeutic misconception: the example of gene transfer research.知情同意书与治疗性误解:基因转移研究实例
IRB. 2005 Jan-Feb;27(1):1-8.